Gastric Residual Volume Measurement in U.K. PICUs: A Survey of Practice.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 29 4 2020
Statut: ppublish

Résumé

Despite little evidence, the practice of routine measurement of gastric residual volume to guide both the initiation and delivery of enteral feeding in PICUs is widespread internationally. In light of increased scrutiny of the evidence surrounding this practice, and as part of a trial feasibility study, we aimed to determine enteral feeding and gastric residual volume measurement practices in U.K. PICUs. An online survey to 27 U.K. PICUs. U.K. PICUs. A clinical nurse, senior doctor, and dietician were invited to collaboratively complete one survey per PICU and send a copy of their unit guidelines on enteral feeding and gastric residual volume. None. Twenty-four of 27 units (89%) approached completed the survey. Twenty-three units (95.8%; 23/24) had written feeding guidelines, and 19 units (19/23; 83%) sent their guidelines for review. More units fed continuously (15/24; 62%) than intermittently (9/24; 37%) via the gastric route as their primary feeding method. All but one PICU routinely measured gastric residual volume, regardless of the method of feeding. Eighteen units had an agreed definition of feed tolerance, and all these included gastric residual volume. Gastric residual volume thresholds for feed tolerance were either volume based (mL/kg body weight) (11/21; 52%) or a percentage of the volume of feed administered (6/21; 29%). Yet only a third of units provided guidance about the technique of gastric residual volume measurement. Routine gastric residual volume measurement is part of standard practice in U.K. PICUs, with little guidance provided about the technique which may impact the accuracy of gastric residual volume. All PICUs that defined feed tolerance included gastric residual volume in the definition. This is important to know when proposing a standard practice arm of any future trial of no-routine gastric residual volume measurement in critically ill children.

Identifiants

pubmed: 31398180
doi: 10.1097/PCC.0000000000001944
pii: 00130478-201908000-00002
pmc: PMC6692165
mid: EMS82038
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-713

Subventions

Organisme : Department of Health
ID : HTA/16/94/02
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

J Crit Care. 2016 Jun;33:137-44
pubmed: 26948254
Nurs Crit Care. 2017 Sep;22(5):293-297
pubmed: 28640510
JAMA. 2013 Jan 16;309(3):249-56
pubmed: 23321763
J Pediatr. 2017 Oct;189:128-134
pubmed: 28625498
Pediatr Neonatol. 2014 Oct;55(5):335-40
pubmed: 25129325
Pediatr Crit Care Med. 2014 Feb;15(2):e49-55
pubmed: 24196008
JPEN J Parenter Enteral Nutr. 2015 May;39(4):434-40
pubmed: 24562002
Crit Care. 2010;14(2):R37
pubmed: 20233424
Am J Nurs. 2012 Jul;112(7):26-35; quiz 46,36
pubmed: 22705494
JPEN J Parenter Enteral Nutr. 2010 Mar-Apr;34(2):125-30
pubmed: 19861528
JPEN J Parenter Enteral Nutr. 1997 Sep-Oct;21(5):286-9
pubmed: 9323691
J Perinatol. 2015 Jan;35(1):57-60
pubmed: 25166623
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Crit Care Med. 2012 Jul;40(7):2204-11
pubmed: 22564954
J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):174-9
pubmed: 26237373
JPEN J Parenter Enteral Nutr. 2010 Jan-Feb;34(1):38-45
pubmed: 19903872
JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1100-1109
pubmed: 28061320
Pediatr Crit Care Med. 2018 Feb;19(2):137-144
pubmed: 29206731
Eur J Pediatr. 2018 Nov;177(11):1675-1683
pubmed: 30116972
Eur J Pediatr. 2017 Dec;176(12):1637-1644
pubmed: 28921175
Br J Nutr. 2013 Apr 14;109(7):1304-22
pubmed: 22853808

Auteurs

Lyvonne N Tume (LN)

Child Health, Faculty of Health & Applied Sciences, University of the West of England, Bristol, United Kingdom.

Barbara Arch (B)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, United Kingdom.

Kerry Woolfall (K)

Department of Health Services Research, MRC Hubs for Trials Methodology Research, University of Liverpool, Liverpool, United Kingdom.

Lynne Latten (L)

Department of Dietetics, Alder Hey Children's Hospital, Liverpool, United Kingdom.

Elizabeth Deja (E)

Department of Health Services Research, University of Liverpool, Liverpool, United Kingdom.

Louise Roper (L)

Department of Health Services Research, University of Liverpool, Liverpool, United Kingdom.

Nazima Pathan (N)

Paediatric Intensive Care, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Helen Eccleson (H)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, United Kingdom.

Helen Hickey (H)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, United Kingdom.

Michaela Brown (M)

Medicines for Children Clinical Trials Unit, Clinical Trials Research Centre, University of Liverpool Institute of Child Health Alder Hey Children's NHS Foundation Trust Liverpool, Liverpool, United Kingdom.

Anne Beissel (A)

Neonatal Intensive Care Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon-Bron, France.

Izabela Andrzejewska (I)

Neonatal Unit/Neonatal, Chelsea and Westminster Hospital, London, United Kingdom.

Chris Gale (C)

Neonatal Medicine, Imperial College London, Chelsea and Westminster Hospital campus, London, United Kingdom.

Frédéric V Valla (FV)

Pediatric Intensive Care Unit, CarMEN INSERM UMR 1060 Equipe INFOLIP, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon-Bron, France.
Faculty of Health & Applied Sciences, University of the West of England, Bristol, United Kingdom.

Jon Dorling (J)

Division of Pediatrics and Neonatal-Perinatal Medicine, Dalhousie University and IWK Health Centre, Halifax, NS, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH